Clinical Trials Sponsored by Proactive Life Inc

Total 383 results

Kezar Life Sciences, Inc.

Recruiting

A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Lupus Nephritis

United States, Korea, Republic of, Australia, Malaysia, Taiwan, South Africa, China, Singapore, United Kingdom, Puerto Rico, Croatia, India, Greece, Spain, Brazil, Philippines, Guatemala, Argentina, Portugal, Colombia
Power Life Sciences Inc.

Not yet recruiting

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

Breast Cancer | Triple Negative Breast Cancer
Power Life Sciences Inc.

Not yet recruiting

Assessment of Rosacea Patients' Clinical Trial Experiences

Rosacea
Power Life Sciences Inc.

Not yet recruiting

Analyzing Clinical Trial Experiences of Colon Cancer Patients

Colon Cancer | Colon Disease
Power Life Sciences Inc.

Not yet recruiting

Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials

Bile Duct Cancer
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Trial Experiences of Patients With Migraine

Migraine | Migraine Disorders
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Trial Experiences of People With Leiomyosarcoma

Leiomyosarcoma
Power Life Sciences Inc.

Not yet recruiting

Finding Patterns In Clinical Study Experiences of Multiple Sclerosis Patients

Multiple Sclerosis
Power Life Sciences Inc.

Not yet recruiting

Analyzing Orthopedic Patient Experience Patterns in Medical Trials

Orthopedic Disorder
Kezar Life Sciences, Inc.

Completed

Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.

Dermatomyositis | Polymyositis

United States, Czechia
Kezar Life Sciences, Inc.

Completed

A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis (PRESIDIO)

Dermatomyositis | Polymyositis

United States, Czechia, Germany
GeneOne Life Science, Inc.

Active, not recruiting

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

SARS-CoV Infection | Pneumonitis

Korea, Republic of, Puerto Rico, United States, Bulgaria, North Macedonia
SK Life Science, Inc.

Completed

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Partial Epilepsy

Australia, United States, Korea, Republic of, Germany, Hungary, Serbia, Bulgaria, Czechia, France, Israel, Poland, Romania, Spain, Thailand, Ukraine
ReAlta Life Sciences, Inc.

Withdrawn

A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure

COVID-19 | Acute Lung Injury | ALI

United States
SK Life Science, Inc.

Completed

Bioavailability and Food Effect Study of Cenobamate as an Oral Suspension and Tablet

Healthy

United States
Inspired Life Medical, Inc.

Completed

Vitamin D Absorbance Study - Clinical Trial of the Absorbance of Nano Liquid D3 (ViDAS)

Vitamin D Deficiency

United States
Bioniche Life Sciences Inc.

Terminated

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer (EMBARC-RF)

Carcinoma in Situ | Neoplasm Recurrence, Local | Bladder Neoplasm | Mycobacterium | Transitional Cell, Carcinoma

United States, Canada, Poland, Germany, Netherlands, United Kingdom
Life Extension Foundation Inc.

Completed

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
SK Life Science, Inc.

Completed

A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy

Painful Diabetic Neuropathy

United States
SK Life Science, Inc.

Completed

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

United States
Bioniche Life Sciences Inc.

Withdrawn

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Bladder Cancer

United States
Alltech Life Sciences Inc.

Completed

Safety and Tolerability of Antioxidant (AT-001)for Reducing Brain Oxidative Stress

Oxidative Stress

United States
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Epilepsy | Epilepsies, Partial | Epilepsy, Complex Partial | Complex Partial Seizures
SK Life Science, Inc.

Completed

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Epilepsy, Complex Partial | Epilepsy, Partial, Motor | Epilepsy, Simple Partial | Focal Motor Epilepsy
SK Life Science, Inc.

Completed

A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.

Epilepsy, Complex Partial | Epilepsy, Partial, Motor | Epilepsy, Simple Partial | Focal Motor Epilepsy
SK Life Science, Inc.

Completed

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

Epilepsy | Epilepsies, Partial
SK Life Science, Inc.

Completed

A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Epilepsy | Epilepsy, Complex Partial | Seizure Disorder | Complex Partial Seizures | Epilepsy, Focal
Afexa Life Sciences Inc

Terminated

GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

Impaired Glucose Tolerance

United States
Afexa Life Sciences Inc

Withdrawn

Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia

Leukemia, Lymphocytic, Chronic, B-Cell

United States
Afexa Life Sciences Inc

Completed

A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Canada
Advanced Life Sciences, Inc.

Completed

Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia

Pneumonia

United States
Advanced Life Sciences, Inc.

Unknown

Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma

Melanoma

United States
SK Life Science, Inc.

Not yet recruiting

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Focal Onset Seizure

United States
Power Life Sciences Inc.

Not yet recruiting

Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study

Soft Tissue Sarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Dynamics Among Semantic Dementia Patients

Semantic Dementia

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Atopic Dermatitis

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns Among Stage IV Melanoma Patients

Stage IV Melanoma

United States
Power Life Sciences Inc.

Not yet recruiting

A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study

Medullary Thyroid Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Lymphoma

Lymphoma

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research

Follicular Lymphoma

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Merkel Cell Carcinoma Clinical Trial Engagement Patterns

Merkel Cell Carcinoma

United States
Power Life Sciences Inc.

Not yet recruiting

Appraising Clinical Trial Experiences of Patients With Insomnia

Insomnia

United States
Power Life Sciences Inc.

Not yet recruiting

Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences

Chronic Fatigue Syndrome

United States
Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research

Glioblastoma Multiforme

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Depression

Depression

United States
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients

Pulmonary Fibrosis

United States
Power Life Sciences Inc.

Not yet recruiting

A Close Examination of Patient Experiences in Bipolar Disorder Clinical Trials

Bipolar Disorder

United States
Power Life Sciences Inc.

Recruiting

Discovering Factors in the Clinical Study Journey of Patients With OCD

Obsessive-Compulsive Disorder | OCD

United States
Power Life Sciences Inc.

Not yet recruiting

An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research

Schizophrenia

Clinical Trials Sponsored by Proactive Life Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations